Trial
NCT05050305
Marizomib Central Nervous System (CNS)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Dana-Farber Cancer Institute
Collaborators
Bristol-Myers Squibb
Condition
Multiple Myeloma
Intervention
Marizomib
Why stopped
Study support withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-16